Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.496 USD | -23.46% |
|
+51.35% | -93.33% |
May. 21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
May. 08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Cingulate Inc.
Upcoming events on Cingulate Inc.
Past events on Cingulate Inc.
2024-06-26 11:30 am | Benzinga All Access Event |
2024-06-11 11:00 am | Annual General Meeting |
2024-05-19 | VEGAS Planet MicroCap Showcase |
2024-05-08 07:00 am | Q1 2024 Earnings Release |
2024-05-03 12:10 pm | Benzinga All Access Event |
2024-05-01 05:30 pm | Planet MicroCap Showcase |
2024-04-29 | Benzinga All Access Event |
2024-04-01 08:00 am | Q4 2023 Earnings Release |
2024-03-17 | Drug Chemical & Associated Technologies Association Meeting |
2023-12-06 02:20 pm | Emerging Growth Conference |
2023-11-13 04:15 pm | Q3 2023 Earnings Release |
2023-11-03 11:00 am | Special Meeting |
2023-10-04 05:30 pm | LD Micro Main Conference |
2023-08-14 04:15 pm | Q2 2023 Earnings Release |
2023-06-22 10:30 am | Maxim Group Virtual Healthcare Conference |
2023-06-15 11:00 am | Annual General Meeting |
2023-06-06 12:30 pm | LD Micro Invitational Conference |
2023-05-10 04:45 pm | Q1 2023 Earnings Release |
2023-03-10 04:05 pm | Q4 2022 Earnings Release |
2023-01-25 | Q1 Investor Summit |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -20,7 -15,6 -32.23% | -17,5 -17,5 0.06% | -22,8 -21,5 -5.76% | -10,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -20,7 -24,0 13.76% | -17,7 -17,6 -0.3% | -23,5 -22,3 -5.65% | -10,5 |
Net income Million USD | Released Forecast Spread | -7,18 | -20,7 -24,0 13.76% | -17,7 -17,6 -0.3% | -23,5 -22,3 -5.65% | -10,5 |
EPS USD | Released Forecast Spread | 0,00 | -55,8 -31,4 -77.71% | -31,2 -30,4 -2.8% | -26,0 -27,8 6.37% | -2,06 |
Announcement Date | 24/05/21 | 10/03/22 | 10/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -5,01 -2,73 -83.69% | -4,05 -6,65 39.14% | -3,97 -4,23 6.13% | -4,48 -4,49 0.4% | -3,85 -4,48 13.99% | -6,36 -5,07 -25.53% | -5,75 -5,74 -0.24% | -6,80 -5,55 -22.52% | -2,95 -5,14 42.69% | -2,58 | -2,51 | -2,45 | -4,00 | -4,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,00 -2,73 -83.14% | -4,04 -6,66 39.33% | -4,03 -4,23 4.77% | -4,61 -4,54 -1.34% | -4,00 -4,52 11.47% | -6,62 -5,14 -28.81% | -5,98 -5,88 -1.65% | -6,93 -5,68 -22.18% | -2,97 -5,19 42.77% | -2,58 | -2,51 | -2,45 | -4,00 | -4,00 |
Net income Million USD | Released Forecast Spread | -5,00 -2,73 -83.14% | -4,04 -6,66 39.33% | -4,03 -4,23 4.77% | -4,61 -4,54 -1.34% | -4,00 -4,52 11.47% | -6,62 -5,14 -28.81% | -5,98 -5,88 -1.65% | -6,93 -5,68 -22.18% | -2,97 -5,19 42.77% | -2,58 | -2,51 | -2,45 | -4,00 | -4,00 |
EPS USD | Released Forecast Spread | -8,80 -4,80 -83.33% | -7,20 -11,6 37.93% | -7,20 -7,40 2.7% | -8,00 -7,45 -7.38% | -7,00 -6,80 -2.94% | -11,4 -7,07 -61.32% | -6,00 -7,40 18.92% | -1,60 -4,86 67.08% | -0,60 -1,17 48.5% | -0,47 | -0,45 | -0,44 | -0,63 | -0,62 |
Announcement Date | 12/05/22 | 11/08/22 | 14/11/22 | 10/03/23 | 10/05/23 | 14/08/23 | 13/11/23 | 01/04/24 | 08/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-22 07:00 am | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Cingulate Inc.
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CING Stock
- Calendar Cingulate Inc.